HYDERABAD: Telangana industries & IT minister KT Rama Rao, who is on a week-long US trip hard-selling Telangana as an investment destination, met top honchos of the world’s top three pharma players — Pfizer, Johnson & Johnson and GlaxoSmithKline — in New York.

Not only did KTR pitch Telangana’s life sciences sector, especially the Hyderabad cluster, he also sought their suggestions on boosting the city’s life sciences innovation quotient and invited them for the 20th edition of BioAsia that is scheduled to be held in February 2023 in Hyderabad.

Click for more articles on Telangana

In a bid to get a sense of the $42 billion turnover Pfizer’s strategy and plans for India’s healthcare and pharma sector, KTR met its chairman & chief executive officer Albert Bourla and also showcased Telangana’s vibrant life sciences ecosystem that accounts for a chunk of the global vaccine supply.

The Telangana delegation, which also included industries department principal secretary Jayesh Ranjan and life sciences director Shakthi M Nagappan, also met Pfizer’s EVP & chief global supply officer Mike McDermott as well as its SVP & chief scientific officer Dr Uwe Schoenbeck.

Click for more articles on Pharma Hub

At the office of the $82 billion turnover J&J, KTR held deliberations with its EVP of pharmaceutical R&D Dr Mathai Mammen.

The minister also met Agam Upadhyay, SVP & chief technology officer, GlaxoSmithKline (GSK), to acquaint him with Hyderabad’s technological and digital innovation capabilities.

NPPA updated price lists: Download

NPPA allows price hike of Essential Medicines by more than 10 percent

WHO establishes Global Centre for Traditional Medicine in India

Maharashtra FDA to get 15 new Asstt. Commissioners to combat impending…

USFDA probe of Abbott facility finds quality control issues

DCGI calls on stakeholders to initiate Clinical Trials early

USFDA gives nod to Lupin for Sildenafil for oral suspension

NPPA’s expert panel recommends retail price for FDCs of anti-diabetic linagliptin

DCGI gives nod to Phase-3 Clinical Trial of Covovax Vaccine

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/03/28/telangana-minister-pitches-hyderabad-as-pharma-hub/